TSAO Derivatives, Inhibitors of HIV-1 Reverse Transcriptase Dimerization: Recent Progress

E-ISSN： 1873-4286|12|15|1895-1907

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.12, Iss.15, 2006-05, pp. : 1895-1907

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

TSAO Compounds: The Comprehensive Story of a Unique Family of HIV- 1 Specific Inhibitors of Reverse Transcriptase

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 9, 2004-05 ,pp. : 945-963

Bentham Science Publishers

Access to resources Recommend Favorite

HIV-1 reverse transcriptase inhibitors

By Krawczyk Sören Hilgeroth Andreas

PHARMAKON, Vol. 2, Iss. 4, 2014-07 ,pp. : 270-276

Govi-Verlag

Access to resources Recommend Favorite

Recent Advances in the Research of 2,3-Diaryl-1,3-thiazolidin-4-one Derivatives as Potent HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors

Current Medicinal Chemistry, Vol. 19, Iss. 13, 2012-05 ,pp. : 2026-2037

Bentham Science Publishers

Access to resources Recommend Favorite

Non-nucleoside inhibitors of HIV-1 reverse transcriptase

By Proudfoot J.R.

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 8, 1998-08 ,pp. : 971-982

Informa Healthcare

Access to resources Recommend Favorite

HIV-1 non-nucleoside reverse transcriptase inhibitors

By Högberg M. Morrison I.

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 8, 2000-08 ,pp. : 1189-1199

Informa Healthcare

Access to resources Recommend Favorite